Patents Assigned to Constant Therapeutics LLC
  • Patent number: 10973869
    Abstract: The present invention provides, among other things, methods of treating a cardiac disease or condition in a patient having muscular dystrophy that can include administering to a subject suffering from, susceptible, or diagnosed with muscular dystrophy an angiotensin (1-7) peptide.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: April 13, 2021
    Assignee: Constant Therapeutics LLC
    Inventor: Richard Franklin
  • Patent number: 10960045
    Abstract: A method of treating epidermolysis bullosa comprising administering to a subject suffering from epidermolysis bullosa an angiotensin (1-7) peptide is described. In some embodiments, methods of treating a complication of epidermolysis bullosa are described including administering to a subject suffering from one or more complications of epidermolysis bullosa an angiotensin (1-7) peptide, wherein the administration results in a reduction in the intensity, severity, duration, or frequency of at least one symptom or feature of the one or more complications of epidermolysis bullosa.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: March 30, 2021
    Assignee: Constant Therapeutics LLC
    Inventor: Richard Franklin